American Society of Clinical Oncology 2011 CNS tumors update

Manmeet Ahluwalia

American Society of Clinical Oncology 2011 CNS tumors update

Manmeet Ahluwalia

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Expert Review of Anticancer Therapy
Volume	11
State	Published - Oct 2011

Disciplines

Medicine and Health Sciences

Cite this

@article{4619c78e7f97411c94dc5ec9700eea83,

title = "American Society of Clinical Oncology 2011 CNS tumors update",

author = "Manmeet Ahluwalia",

note = "A number of important studies were presented at the CNS tumors section of the 2011 American Society of Clinical Oncology Annual Meeting. There was particular interest in RTOG 0525, a Phase III study of newly diagnosed glioblastoma treated with different schedules of temozolomide. Prognostic factors ...",

year = "2011",

month = oct,

language = "American English",

volume = "11",

journal = "Expert Review of Anticancer Therapy",

}

TY - JOUR

T1 - American Society of Clinical Oncology 2011 CNS tumors update

AU - Ahluwalia, Manmeet

N1 - A number of important studies were presented at the CNS tumors section of the 2011 American Society of Clinical Oncology Annual Meeting. There was particular interest in RTOG 0525, a Phase III study of newly diagnosed glioblastoma treated with different schedules of temozolomide. Prognostic factors ...

PY - 2011/10

Y1 - 2011/10

UR - https://pubmed.ncbi.nlm.nih.gov/21999122/

M3 - Article

VL - 11

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

ER -

American Society of Clinical Oncology 2011 CNS tumors update

Disciplines

Other files and links

Cite this